Peptide / Protein /Single-cell Map Of The Renin-angiotensin System In Covid-19 (RAS CoV-2)
- Funded by Luxembourg National Research Fund
- Total publications:0 publications
Grant number: unknown
Grant search
Key facts
Disease
COVID-19Known Financial Commitments (USD)
$38,880Funder
Luxembourg National Research FundPrincipal Investigator
Antonio CosmaResearch Location
LuxembourgLead Research Institution
Luxembourg Institute of Health (LIH)Research Priority Alignment
N/A
Research Category
Pathogen: natural history, transmission and diagnostics
Research Subcategory
Pathogen morphology, shedding & natural history
Special Interest Tags
N/A
Study Type
Non-Clinical
Clinical Trial Details
N/A
Broad Policy Alignment
Pending
Age Group
Unspecified
Vulnerable Population
Unspecified
Occupations of Interest
Unspecified
Abstract
Receptors for entry of SARS-CoV-2 into lung pneumocytes belong to the renin-angiotensin system (RAS) and diseases that are associated to a dysregulation of the same system (e.g.: diabetes, hypertension, and cardiovascular diseases) are thought to be associated with a bad Covid-19 prognosis. These receptors are also expressed on cells of the immune system, which is involved in diseases associated to RAS dysregulation. Our project plan to employ an integrated mass spectrometry / flow cytometry approach to build a quantitative map of the RAS, at the peptide and protein level together with a single cell analysis of the immune cells in individuals infected by the SARS-CoV-2. The aim of the project is to use this integrated map together with data and metadata generated by running clinical trials to find correlations to Covid-19 prognosis. We expect to build a mechanistic model on how viral infection modulates the RAS, the immune system, and the expression of the receptors. Finally, we wish to find a potential biomarker for Covid-19 prognosis by a simple flow cytometric assay transferable to the clinic.